Glenmark Recalls Generic Of Singulair Asthma Drug In Smelly Bottles
This article was originally published in PharmAsia News
Executive Summary
Glenmark Pharmaceuticals recalled its allergy and asthma drug following reports of 29 batches of the bottled treatment emitted musty odors of preservative chemicals.